VSee Health

Q2 FY2026 EarningsQ2 FY26 results significantly missed consensus estimates on the top line and margins, despite a technical beat on EPS caused by massive share dilution. Revenue of $1.56M fell 69.75% short of the $5.16M expected, while gross margin collapsed to 13.20% compared to the 69.00% mean estimate. The variance was driven by a pivot to a high-cost teleradiology contractor model and significant client attrition in legacy Tele-ICU services. Management issued a going concern warning and confirmed the stock's delisting from Nasdaq as of August 6, 2026.